Which end point is more comprehensive in reflecting changes in irritable bowel syndrome treatment trials?

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2859-

  Gholamrezaei, Ali ^a,b   Nemati, Kianoosh ^a   Emami, Mohammad Hassan ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Poursina Hakim Research Institute   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; IRRITABLE COLON; LETTER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SYMPTOMATOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TIME FACTORS; TREATMENT OUTCOME;

EID: 72049095079     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.486     Document Type: Letter

References (2)

1. Passos MCF, Lembo AJ, Conboy LA et al. Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol 2009;104:912-919
2. Irvine EJ, Whitehead WE, Chey WD et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-1551